Your privacy, your choice

We use essential cookies to make sure the site can function. We also use optional cookies for advertising, personalisation of content, usage analysis, and social media.

By accepting optional cookies, you consent to the processing of your personal data - including transfers to third parties. Some third parties are outside of the European Economic Area, with varying standards of data protection.

See our privacy policy for more information on the use of your personal data.

for further information and to change your choices.

Skip to main content

Table 2 Grading of recommendations, assessment, development, and evaluation

From: Effect of Astragalus injection treatment for viral myocarditis: a systematic review and meta-analysis

Outcomes

N

Design

Certainty assessment

Patients

Effect WMD/OR(95%CI)

Quality

Risk of bias

Inconsistency

Indirectness

Imprecision

Others

T

C

CK

9

RCT

No serious

No serious

Serious

Serious

No serious

481

440

− 34.83 (− 48.03,− 21.65)

Moderate

AST

9

RCT

No serious

No serious

Serious

No serious

No serious

407

380

− 14.23 (− 24.17,− 4.30)

Moderate

CK-MB

20

RCT

No serious

No serious

Serious

No serious

No serious

1058

1022

− 7.64 (− 9.30,− 5.99)

Moderate

LDH

14

RCT

No serious

No serious

Serious

No serious

No serious

850

812

− 41.93 (− 55.97,− 27.90)

Moderate

cTnI

12

RCT

No serious

No serious

No serious

No serious

No serious

679

644

− 0.18 (− 0.27,− 0.10)

High

ECG

9

RCT

No serious

No serious

No serious

No serious

No serious

457

438

2.51 (1.66, 3.81)

High

  1. T: treatment group; C: control group; N: number